NM_014324.6:c.712C>T

Variant names:

• chr5-33998668-G-A
• rs9282594
• NM_014324.6:c.712C>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_014324.6(AMACR):​c.712C>T​(p.Pro238Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00445 in 1,612,120 control chromosomes in the GnomAD database, including 268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.024 (144 hom., cov: 32)
  • Exomes 𝑓: 0.0024 (124 hom.)
• Consequence: AMACR NM_014324.6 missense
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:5
• Conservation: PhyloP100: 5.45

Genes affected

AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]

ENSG00000289791 (HGNC:):

C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (MetaRNN=0.0028857589).
• BP6: Variant 5-33998668-G-A is Benign according to our data. Variant chr5-33998668-G-A is described in ClinVar as [Benign]. Clinvar id is 353254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0811 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
AMACR	NM_014324.6	c.712C>T	p.Pro238Ser	missense_variant	Exon 4 of 5	ENST00000335606.11	NP_055139.4
AMACR	NM_001167595.2	c.712C>T	p.Pro238Ser	missense_variant	Exon 4 of 6		NP_001161067.1
AMACR	NM_203382.3	c.551C>T	p.Thr184Ile	missense_variant	Exon 3 of 4		NP_976316.1
C1QTNF3-AMACR	NR_037951.1	n.1068C>T		non_coding_transcript_exon_variant	Exon 8 of 9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
AMACR	ENST00000335606.11	c.712C>T	p.Pro238Ser	missense_variant	Exon 4 of 5	1	NM_014324.6	ENSP00000334424.6
ENSG00000289791	ENST00000382068.3	c.551C>T	p.Thr184Ile	missense_variant	Exon 3 of 4	1		ENSP00000477108.1
C1QTNF3-AMACR	ENST00000382079.3	n.*138C>T		non_coding_transcript_exon_variant	Exon 8 of 9	2		ENSP00000371511.3
C1QTNF3-AMACR	ENST00000382079.3	n.*138C>T		3_prime_UTR_variant	Exon 8 of 9	2		ENSP00000371511.3

Frequencies

GnomAD3 genomes AF: 0.0238 AC: 3615 AN: 151946 Hom.: 141 Cov.: 32

Gnomad AFR AF: 0.0831

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00860

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.000622

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00633

Gnomad NFE AF: 0.000191

Gnomad OTH AF: 0.0159

GnomAD3 exomes AF: 0.00629 AC: 1578 AN: 250676 Hom.: 68 AF XY: 0.00474 AC XY: 642 AN XY: 135480

Gnomad AFR exome AF: 0.0861

Gnomad AMR exome AF: 0.00349

Gnomad ASJ exome AF: 0.0000996

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.000164

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000326

Gnomad OTH exome AF: 0.00278

GnomAD4 exome AF: 0.00242 AC: 3539 AN: 1460056 Hom.: 124 Cov.: 31 AF XY: 0.00207 AC XY: 1501 AN XY: 726038

Gnomad4 AFR exome AF: 0.0849

Gnomad4 AMR exome AF: 0.00419

Gnomad4 ASJ exome AF: 0.0000383

Gnomad4 EAS exome AF: 0.0000252

Gnomad4 SAS exome AF: 0.000244

Gnomad4 FIN exome AF: 0.00

Gnomad4 NFE exome AF: 0.000123

Gnomad4 OTH exome AF: 0.00519

GnomAD4 genome AF: 0.0239 AC: 3637 AN: 152064 Hom.: 144 Cov.: 32 AF XY: 0.0229 AC XY: 1700 AN XY: 74356

Gnomad4 AFR AF: 0.0834

Gnomad4 AMR AF: 0.00852

Gnomad4 ASJ AF: 0.00

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.000622

Gnomad4 FIN AF: 0.00

Gnomad4 NFE AF: 0.000191

Gnomad4 OTH AF: 0.0157

Alfa AF: 0.00549 Hom.: 61

Bravo AF: 0.0279

TwinsUK AF: 0.00 AC: 0

ALSPAC AF: 0.000519 AC: 2

ESP6500AA AF: 0.0790 AC: 348

ESP6500EA AF: 0.000349 AC: 3

ExAC AF: 0.00786 AC: 954

Asia WGS AF: 0.00491 AC: 18 AN: 3478

EpiCase AF: 0.000328

EpiControl AF: 0.000296

ClinVar

Significance: Benign

Submissions summary: Benign:5

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:2

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Dec 16, 2015

Mayo Clinic Laboratories, Mayo Clinic

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Alpha-methylacyl-CoA racemase deficiency Benign:2

Feb 04, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1

Dec 10, 2015

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.22
BayesDel_addAF	Benign	-0.42	T
BayesDel_noAF	Benign	-0.31
CADD	Uncertain	25
DANN	Uncertain	1.0
DEOGEN2	Benign	0.25	T;.;.;T;T
Eigen	Uncertain	0.66
Eigen_PC	Uncertain	0.60
FATHMM_MKL	Pathogenic	0.97	D
LIST_S2	Pathogenic	0.98	D;D;D;D;D
MetaRNN	Benign	0.0029	T;T;T;T;T
MetaSVM	Benign	-0.58	T
MutationAssessor	Uncertain	2.2	M;M;.;.;.
PrimateAI	Uncertain	0.49	T
PROVEAN	Pathogenic	-6.0	D;D;D;.;.
REVEL	Uncertain	0.31
Sift	Benign	0.056	T;D;T;.;.
Sift4G	Uncertain	0.046	D;D;D;D;D
Polyphen		0.83	P;.;P;.;.
Vest4		0.30
MVP		0.74
MPC		0.12
ClinPred		0.051	T
GERP RS		5.3
Varity_R		0.47
gMVP		0.78

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs9282594; hg19: chr5-33998773;